DK1114641T3 - Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre - Google Patents

Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre

Info

Publication number
DK1114641T3
DK1114641T3 DK01107733T DK01107733T DK1114641T3 DK 1114641 T3 DK1114641 T3 DK 1114641T3 DK 01107733 T DK01107733 T DK 01107733T DK 01107733 T DK01107733 T DK 01107733T DK 1114641 T3 DK1114641 T3 DK 1114641T3
Authority
DK
Denmark
Prior art keywords
inhibiting
degradation
methods
lewis acid
fluoroether
Prior art date
Application number
DK01107733T
Other languages
English (en)
Inventor
Christopher Bieniarz
Rajagopalan Raghavan
Steve H Chang
Shuyen L Huang
Toshikazu Kawai
Manami Kobayashi
David Loffredo
Earl R Speicher
Keith R Cromack
Honorate A Stelmach
Original Assignee
Abbott Lab
Central Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25148366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1114641(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab, Central Glass Co Ltd filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1114641T3 publication Critical patent/DK1114641T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
DK01107733T 1997-01-27 1998-01-23 Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre DK1114641T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/789,679 US5990176A (en) 1997-01-27 1997-01-27 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
EP98902707A EP0967975B1 (en) 1997-01-27 1998-01-23 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid

Publications (1)

Publication Number Publication Date
DK1114641T3 true DK1114641T3 (da) 2006-05-15

Family

ID=25148366

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98902707T DK0967975T3 (da) 1997-01-27 1998-01-23 Fluorethersammensætninger og fremgangsmåde til at inhibere nedbrydningen af disse i nærværelse af en Lewis-syre
DK01107733T DK1114641T3 (da) 1997-01-27 1998-01-23 Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK98902707T DK0967975T3 (da) 1997-01-27 1998-01-23 Fluorethersammensætninger og fremgangsmåde til at inhibere nedbrydningen af disse i nærværelse af en Lewis-syre

Country Status (28)

Country Link
US (6) US5990176A (da)
EP (2) EP0967975B1 (da)
JP (5) JP3183520B2 (da)
KR (1) KR100368672B1 (da)
CN (3) CN1321958C (da)
AR (2) AR011090A1 (da)
AT (2) ATE201987T1 (da)
AU (1) AU726733B2 (da)
BG (2) BG65414B1 (da)
BR (1) BR9806996A (da)
CA (2) CA2278133C (da)
CO (1) CO4920220A1 (da)
CZ (1) CZ297092B6 (da)
DE (2) DE69800928T2 (da)
DK (2) DK0967975T3 (da)
ES (2) ES2170474T3 (da)
GR (1) GR3036190T3 (da)
HK (1) HK1074434A1 (da)
HU (1) HUP0002101A3 (da)
IL (1) IL130150A (da)
NO (1) NO993606L (da)
NZ (1) NZ335994A (da)
PL (1) PL334477A1 (da)
PT (2) PT1114641E (da)
SK (1) SK284243B6 (da)
TR (1) TR199901579T2 (da)
WO (1) WO1998032430A1 (da)
ZA (1) ZA98418B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
US20030200963A1 (en) * 1998-01-09 2003-10-30 Flament-Garcia Mary Jane Container for an inhalation anesthetic
US6074668A (en) * 1998-01-09 2000-06-13 Abbott Laboratories Container for an inhalation anesthetic
US6162443A (en) 1998-01-09 2000-12-19 Abbott Laboratories Container for an inhalation anesthetic
US7097849B2 (en) * 1998-08-19 2006-08-29 Jagotec Ag Injectable aqueous dispersions of propofol
EP1530336B1 (en) 1999-01-08 2009-06-10 Sony Deutschland GmbH Synchronization preamble structure for OFDM system
TW523409B (en) * 2000-09-15 2003-03-11 Baxter Int Container for inhalation anesthetic
BR0303489A (pt) * 2003-09-10 2005-07-05 Cristalia Prod Quimicos Farm Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter
EP1663186B1 (en) * 2003-09-10 2007-06-20 Cristália Produtos Químicos Farmacêuticos Ltda. Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
CN101180250B (zh) * 2005-04-18 2013-05-22 皮拉莫危急护理有限公司 含水量可忽略的七氟烷的制备方法
WO2009049460A1 (fr) * 2007-10-15 2009-04-23 Jiangsu Hengrui Medicine Co., Ltd. Nouveau matériau conditionné de sévoflurane
CN107661293A (zh) * 2008-01-22 2018-02-06 得克萨斯大学体系董事会 用于局部麻醉和/或疼痛缓解的含有萃取溶剂的挥发性麻醉剂组合物
US20090275785A1 (en) * 2008-05-01 2009-11-05 Barry Jones Distillation Method For The Purification Of Sevoflurane And The Maintenance Of Certain Equipment That May Be Used In The Distillation Process
US8563115B2 (en) * 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8092822B2 (en) * 2008-09-29 2012-01-10 Abbott Cardiovascular Systems Inc. Coatings including dexamethasone derivatives and analogs and olimus drugs
US8283643B2 (en) * 2008-11-24 2012-10-09 Cymer, Inc. Systems and methods for drive laser beam delivery in an EUV light source
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
US9278048B2 (en) * 2009-05-06 2016-03-08 Baxter International, Inc. Pharmaceutical product and method of use
US9102604B1 (en) 2010-02-15 2015-08-11 Baxter International Inc. Methods for cleaning distilling columns
CN105106182B (zh) * 2015-09-21 2017-12-29 山东新时代药业有限公司 七氟烷吸入剂
CN105193774B (zh) * 2015-09-21 2018-01-16 山东新时代药业有限公司 一种七氟烷吸入剂
BE1024432B1 (fr) 2016-11-02 2018-02-19 Central Glass Company, Limited Procédé pour le lavage de récipient de stockage de sévoflurane et procédé pour le stockage de sévoflurane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2992276A (en) * 1959-05-20 1961-07-11 Du Pont Process for preparing polyfluoro alkyl compounds
US3527813A (en) * 1966-10-03 1970-09-08 Air Reduction 1,1,2 - trifluoro - 2 - chloroethyl difluoromethyl ether and its method of preparation
US3689571A (en) * 1970-07-31 1972-09-05 Baxter Laboratories Inc Fluorinated ether
GB1499818A (en) * 1974-12-06 1978-02-01 Ici Ltd Anaesthetic composition
US4469898A (en) * 1979-12-26 1984-09-04 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
US4250334A (en) * 1979-12-26 1981-02-10 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
JP2786108B2 (ja) 1994-03-31 1998-08-13 セントラル硝子株式会社 フルオロメチル−１，１，１，３，３，３−ヘキサフルオロイソプロピルエーテルの精製方法
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
US5990176A (en) 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

Also Published As

Publication number Publication date
SK86199A3 (en) 2000-06-12
BG109751A (bg) 2008-06-30
PL334477A1 (en) 2000-02-28
US20030130359A1 (en) 2003-07-10
US20020016373A1 (en) 2002-02-07
JP2006137769A (ja) 2006-06-01
DE69833884T2 (de) 2006-08-24
CN1899271A (zh) 2007-01-24
NO993606L (no) 1999-09-24
EP0967975A1 (en) 2000-01-05
EP1114641A3 (en) 2003-05-28
US6444859B2 (en) 2002-09-03
ZA98418B (en) 1999-04-20
CA2626424A1 (en) 1998-07-30
JP3664648B2 (ja) 2005-06-29
NO993606D0 (no) 1999-07-23
ES2170474T3 (es) 2002-08-01
AR011090A1 (es) 2000-08-02
BG103656A (en) 2000-04-28
PT1114641E (pt) 2006-05-31
JP2006143742A (ja) 2006-06-08
CO4920220A1 (es) 2000-05-29
CA2278133C (en) 2001-06-26
DE69800928T2 (de) 2001-11-22
AR057610A2 (es) 2007-12-05
EP0967975B1 (en) 2001-06-13
HUP0002101A2 (hu) 2001-05-28
HUP0002101A3 (en) 2002-03-28
PT967975E (pt) 2001-11-30
AU726733B2 (en) 2000-11-16
DE69800928D1 (de) 2001-07-19
JP2000510159A (ja) 2000-08-08
JP2005279283A (ja) 2005-10-13
US20040048932A1 (en) 2004-03-11
HK1074434A1 (en) 2005-11-11
US6677492B2 (en) 2004-01-13
TR199901579T2 (xx) 1999-12-21
US20060148906A1 (en) 2006-07-06
CZ297092B6 (cs) 2006-09-13
ATE201987T1 (de) 2001-06-15
IL130150A0 (en) 2001-03-19
KR20000070482A (ko) 2000-11-25
SK284243B6 (sk) 2004-12-01
AU5930098A (en) 1998-08-18
BG65414B1 (bg) 2008-07-31
WO1998032430A1 (en) 1998-07-30
ES2256104T3 (es) 2006-07-16
KR100368672B1 (ko) 2003-01-24
CN1152674C (zh) 2004-06-09
JP2001187729A (ja) 2001-07-10
ATE320798T1 (de) 2006-04-15
DE69833884D1 (de) 2006-05-11
GR3036190T3 (en) 2001-10-31
IL130150A (en) 2004-09-27
CZ256199A3 (cs) 1999-11-17
CN1560003A (zh) 2005-01-05
CN1321958C (zh) 2007-06-20
EP1114641B1 (en) 2006-03-22
JP3183520B2 (ja) 2001-07-09
DK0967975T3 (da) 2001-09-17
US5990176A (en) 1999-11-23
CA2278133A1 (en) 1998-07-30
EP1114641A2 (en) 2001-07-11
NZ335994A (en) 2000-08-25
BR9806996A (pt) 2000-03-14
CN1244797A (zh) 2000-02-16
US6288127B1 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
DK1114641T3 (da) Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre
DK1148875T3 (da) Fremgangsmåder og sammensætninger til forögelse af antallet af hvide blodlegemer
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
DK0785770T3 (da) Sammensætninger til bekæmpelse af hæmorroider og fremgangsmåde til anvendelse deraf
DK0980240T3 (da) Sammensætninger med lang frigivelse og fremgangsmåde til fremstilling heraf
DK0969846T3 (da) Sammensætninger og fremgangsmåder til reduktion af okulær hypertension
NO20012097L (no) Fremgangsmåter og sammensetninger for forebygging av toleranse for medisineringer
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO973046D0 (no) Elastiske sementsammensetninger og fremgangsmåte
DK1105122T3 (da) Pharmaceutical compositions containing lipase inhibitors
DK0946190T3 (da) Fremgangsmåder og sammensætninger til stimulering af neuritvækst
NO994216D0 (no) Sementsammensetninger og bionedbrytbare dispergeringsmidler derfor
NO973048L (no) Elastiske brönnsementsammensetninger og fremgangsmåter
DK1112174T3 (da) Isosorbidholdige polyestere og fremgangsmåder til fremstiling heraf
NO965327D0 (no) Sporbare brönnsementsammensetninger og metoder
DE69818942D1 (de) Stanolester enthaltende Zusammensetzungen
NO20003067L (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
DK0977812T3 (da) Asfaltsammensætninger og fremgangsmåder til fremstilling deraf
DE69837482D1 (de) Entschäumende zusammensetzungen
NO985385L (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
DE69830262D1 (de) Stress-resistente Pflanze
DE69804218D1 (de) Zementzusammensetzung
BR9711811A (pt) Composi-{es insenticidas
NO20010248D0 (no) Transdermalt plaster og topiske sammensetninger omfattende propylnorapomorfin
NO991749D0 (no) Sammensetninger til bruk i betong og betongprodukter fremstilt derav